Experimental Study on Growth Inhibition Against Anaplastic Thyroid Carcinoma of Animal Model by Application of Ginsenoside Rg1
Wei-Qin Chang,Yang Lin,Dong Li,Ming-Xing Sui,Zhi-Min Wang,Man-Hua Cui,Tian-Min Xu
DOI: https://doi.org/10.1142/9789814719810_0024
2016-01-01
Abstract:Objective: observe the growth inhibition against anaplastic thyroid carcinoma of animal model application of ginsenoside Rg(1) and its influence on life extension. Method: observe the inhibition of Rg(1) against the growth of anaplastic thyroid carcinoma cell strains through dye exclusion experiment in vitro. In vivo, establish the anaplastic thyroid carcinoma animal model, divide the mice bearing tumor into 6 groups randomly, i.e., Rg(1) 3, 1, 0.3 mg.kg(-1) groups, solvent control group; administer drug into thyroid daily for 10 days, kill the animals after stopping administration for 24h, weigh them and tumors, and calculate the tumor growth inhibition rate (%) and Coefficient of Drug Interaction (CDI). Additionally, establish the cell TA-K tumor model, assign the animals into Rg(1) 3, 1, 0.3 mg.kg(-1) groups, solvent control group, randomly, administer drug into abdominal cavity daily for 5 days, record the mouse survival days, and calculate the life extension. Result: in the in vitro experiments, Rg(1) inhibits the growth of anaplastic thyroid carcinoma cells, and its IC50 value is 22 +/- 3.25. In the in vivo experiments, Rg(1) inhibits the growth of anaplastic thyroid carcinoma significantly, Rg(1) extend the survival time of mice bearing tumor, Conclusion: Rg(1) can inhibit the growth of tumor significantly, and extend the survival time of mice bearing tumor; additionally, Rg(1) can improve the anti-tumor.